Randomized Trialhigh evidence
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
The New England journal of medicine·April 18, 2024·PMID 38587241
Why it mattersThis trial addresses a common clinical scenario where beta-blockers are routinely prescribed post-MI despite limited evidence in the modern reperfusion era for patients with preserved LVEF. It provides high-quality data to guide de-escalation or avoidance of beta-blockers in this population.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled